Monday, December 10, 2007

Spare Parts

Updated 3/2017-- photos and all links removed as many are no longer active and it was easier than checking each one.


I would like to direct you to a wonderful post on medical implants, Spare Parts. It is written by Lakshmi Gopal over at Nonoscience. She starts off:

"Soon after a deadline has passed, I end up treating myself to a movie, and this time, it was Hot Shots Part Deux. The only thing that made an impact on a brain fresh (or would that be exhausted?) with materials design was the various implants in the body of President Tug Benson. The president had ceramic eyes, asbestos skin, magnetic skull plate, aluminum siding facial bones, and stainless steel ear canals.


Artificial implants have been known for a long time [1]. My grandmother tells me that my ancestors had golden tooth implants, to showcase their wealth. I am told that after a certain age, they would pull out their perfectly normal teeth and replace them with gold and silver tooth (depending upon their financial position) and swore off manangombu and mysore paks for the rest of their lives. If I were given the choice between golden teeth and murukku , I would most definitely choose the latter. But I digress.
The first recorded case of implant was an accident. In 1952, Per Ingvar Branemark, a Swedish orthopedic surgeon was following the processes of bone healing by embedding microscope heads made of titanium metal in holes drilled into thighbone of anesthetized rabbits. .............."
She goes through a list that includes hip implants, artificial bones, dental implants, eye implants, biologic stents, materials used in cranioplasty, facial implant materials, etc. It is well worth reading.

SurgeXperience 110 is up!

Updated 3/2017--  all links (except to my own posts) removed as many are no longer active and it was easier than checking each one.


The 10th edition of SurgeXperiences has been posted by Dr. Alice over at “Cut on the dotted line”. So head over and check it out.
The next edition of SurgExperiences will be hosted by Buckeye Surgeon on December 23. So feel free to submit a post (or two) regarding your experience with surgery here. The deadline for submission is December 21st.
And if you missed any of the earlier editions:
SurgeXperience 101:Pilot --Monash Med Student
SurgeXperience 102: Barbers --Monash Med Student
SurgeXperience 103-- Unbounded Medicine
SurgeXperience 104 -- other things amanzi
SurgeXperience 105 -- Suture for a Living
SurgeXperience 106 -- IntraopOrate
SurgeXperience 107 --Vitum Medicinus
SurgeXperience 108 -- Aggravated Doc Surg
SurgeXperience 109 -- Monash Med Student

Sunday, December 9, 2007

Skin Complications from Drug Abuse

Updated 3/2017-- photos and all links removed as many are no longer active and it was easier than checking each one.


Skin and soft tissue infections (SSTIs) are common among injection drug users (IDUs). Subcutaneous and intramuscular injection ("skin-popping") and the injection of "speedballs" (a mixture of heroin and cocaine) are risk factors for SSTIs in this patient population. Female IDUs appear to be at greater risk of SSTIs than male IDUs, most likely because of more difficult venous access. Most information regarding the microbiology of SSTIs in IDUs comes from data on skin and subcutaneous abscesses, where Staphylococcus aureus and organisms that originate from the oral flora predominate. These skin and subcutaneous abscesses (often hand/forearm) are the infections I saw as a resident. I haven't seen any in my practice. This doesn't delude me into thinking it has lessened.
Other uncommon outbreaks and infections including tetanus, wound botulism, and a sepsis/myonecrosis syndrome due to Clostridium species.
Skin infections in drug users are not only from injection. Methamphetamine use can cause formication. This is a sensation of something crawling on the body or under the skin. This can lead to skin-picking behavior, skin breakdown, and portals of infection. These may be anywhere (face, arm, torso, legs, etc) and do not "follow" vascular access routes.
Local complications occur at the site or in the area of injection. They can be broken down into two types:
Acute complications occurring within a few hours to 48-72 hr after injection.
  • Recent injection marks at the site of injection are present in all IDUs. These are also present in "therapeutic" injections done by nurses or other medical personnel. I always have an "injection mark" after giving blood for a couple of days afterwards. These are not only due to the "trauma" from the injection but can be made worse by the actual drug injected.
  • Cutaneous infections are common in IDUs. Abscesses (picture at right) and cellulitis occur in 22-65% of addicts. A combination of factors favor these infections. They include --contamination of the street drug used, absence of skin asepsis, unsterile equipment poor hygiene, and the act of indtradermal injection. The simple use of alcohol to clean the skin before injection may protect against cutaneous infections.
  • Necrotizing fasciitis (NF) is a rare but severe and life-threatening manifestation with a high rate of mortality and amputation NF occurs mainly after subcutaneous injection.
  • Necrotizing ulcers and cutaneous necrosis ulcers are most likely similar to the reaction of chemotherapy extravasation. They develop as a result of several combined factors -- mainly 'skin popping', toxicity and the irritant properties of the drug and adulterants, vascular thrombosis and infection. Quinine, for example, is used as an adulterant and has caustic effects. Cocaine has potent vasoconstrictive and thrombotic effects. Though most authors consider the mechanism to be related not to an infection but to a direct effect of the drug or adulterants, bacteria may be cultivated from necrotic ulcers and, in some cases infection may contribute to the formation of ulcerated lesions. Cutaneous necrosis also results from arterial thrombosis after direct intra-arterial injection such as scrotal skin necrosis after pudendal artery injection.
  • False aneurysm and mycotic aneurysms are rare but serious complications. False aneurysm is caused by vascular injuries after drug injection. Staph. aureus is the main pathogen in mycotic aneurysms. Most cases involve the femoral artery following groin injection but other locations such as the upper limbs have been described. The lesion manifests as a pulsatile mass located in the area of major arteries. In some case it may present as a non-pulsatile inflammatory mass and may be mistaken for a cutaneous abscess. If the local of the "abscess" is near or over an artery, aspirate prior to incision as an inappropriate incision can be disastrous. The treatment is difficult, and is based on ligation and surgical excision of the aneurysm.
  • Thrombophlebitis can occur from repeated trauma of venepuncture, local infections and the irritating qualities of the drugs and adulterants. These are causes for both superficial and deep venous thrombosis. Septic thrombosis is responsible for bacteraemia, with Staph. aureus as the most frequent pathogen. High-risk locations include iliofemoral and upper limb deep thrombosis.
  • Intra-arterial injections, whether inadvertent or deliberate, may cause severe tissue ischemia and necrosis. Immediately after injection, the patient will feel intense pain and burning. Within a few hours a marked edema will appear, followed by cyanosis in the territory of the artery. In the most severe cases necrosis occurs and can lead to amputation. Several mechanisms have been suggested to explain the vascular injury: 1) direct vasoconstriction may be caused by cocaine or amphetamines, 2) local chemical toxicity of drugs or adulterants may cause chemical endarteritis resulting in vasospasm and thrombosis, 3) and the mixture may contain microparticles that act as emboli. Microparticles is particularly the case when oral drug formulations such as crushed tablets are injected (as in the picture below). The result is a peripheral ischemia, edema and compartment syndrome, which will worsen the ischemia.

Delayed complications
  • Hyperpigmentation at the site of injection has been found to be the most common cutaneous finding, present in 54% of subjects. It is related to scars and tracks along the injected veins. Hyperpigmentation results from a postinflammatory process following the various skin injuries.

  • Scars and, in particular, needle tracks are the main stigmata of narcotic abuse . Most IDUs have scars along a vascular distribution, mainly the ante-cubital area and the dorsum of the hand. Repeated injections along a superficial vein can result in venous thrombosis and subsequent fibrosis to form linear cord-like hypopigmented or hyperpigmented scars ('railroad tracks') pathognomonic of intravenous drug addiction. 'Pop scars' (see above picture) form irreversible irregular round or oval hypopigmented or hyperpigmented, atrophic or hypertrophic scars, or keloids, 0.5-3 cm in diameter. The IDU may also have other scars resulting from various (indirect drug use ) skin injuries from trauma, infections, necrosis, burns, suicide scars, etc.
  • Chronic venous insufficiency and ulcers may be found in 88% of people with a history of injection drug abuse. Risk factors for the development of venous insufficiency include vein trauma, necrotic ulcers, superficial and deep vein thrombosis and blockage of the lymphatic system by repeated infections and the sclerosing effects of adulterants. Both lymphatic blockage and venous impairment contribute to chronic edema of the lower extremities and therefore to delayed leg ulcers.
Primary prevention strategies to reduce STIs among IDUs include
  • Preventing initiation of injection drug use
  • Increasing entry and retention of IDUs in substance abuse treatment (particularly methadone maintenance).
For IDUs who continue to inject drugs,
  • Increasing access to sterile injection equipment and alcohol swabs
  • Promoting hygiene (including hand washing, cleaning the injection site before injection, using a sterile syringe for every injection, and avoiding needle contamination) are important prevention goals.
Secondary prevention strategies include
  • promoting earlier medical and surgical treatment of STIs.
  • Microbiologic testing of street samples of black tar heroin also may help identify the causes of injection-related STI.
  • Ongoing research into the behavioral and biologic risk factors for STI may identify additional prevention interventions
References
Cutaneous Complications of Intravenous Drug Abuse --MedScape Article
Care of Injection Drug Users With Soft Tissue Infections in San Francisco, California; Hobart W. Harris, MD, MPH; David M. Young, MD; Arch Surg. 2002;137:1217-1222.
Skin Infections in IV Drug Users -- DermNet NZ
Methamphetamine Use and Methicillin-Resistant Staphylococcus aureus Skin Infections -- MedScape Article, Posted 11/19/2007
A Guide for Understanding Steroids and Related Substances, March 2004 -- US DEA Office of Diversion Control
Skin and Soft Tissue Infections in Injection Drug Users; Current Infectious Disease Reports, Volume 4, No 5, pp 415-419, September 2002; Patricia D. Brown and John R. Ebright
Classifying Skin Lesions of Injection Drug Users -- Center for Substance Abuse Treatment, 2002; Cagle, H.H; Fisher, D.G.; Senter, T.P.; Thurmond, R.D.; and Kastar, A.J. (has some nice photos for reference)
Soft Tissue Infections Among Injection Drug Users --- San Francisco, California, 1996--2000 -- MedScape Article


Saturday, December 8, 2007

Ready for Christmas

This is the last Christmas tree quilt I made. It is a miniature which I call "Ready for Christmas". It is 15" X 18" in size. The bows are the tree are metallic buttons sewn on and the white ornaments are beads. The stockings are "hanging freely" stitched only at the hooks.

The dog has his bone (a novelty button).
The doll and bear are waiting to be loved.

Friday, December 7, 2007

A Christmas Tree Quilt

This small wall hanging quilt, 31.5" X 31.5", I simply called "A Christmas Tree". It is mostly machine pieced with appliqued flames for the candles. It is machine quilted using the "in-the-ditch" method. I then attached by safety pins (through the back) minature ornaments. The stockings are freely detachable (pinned on by their loops). One has a minature golf club in it (I don't play) and the other a candy cane. It was made in 1991.

The ornament at the "heart" of the tree was initially a minature nativity scene, but it disappeared the first year it hang in my office. I replaced it with this heart ornament that opens and shows the family.

Thursday, December 6, 2007

Preparing for Christmas

#1 Dino over at Musings of a Dinosaur has been showing off his beautiful Menorahs! So I thought I would show you a few of my Christmas quilts. This one is called "Preparing for Christmas". The log cabin pattern has the colors arranged to form the tree. I left the tree undecorated on purpose. I had Peg (of Peg's Quality Quilting in Iowa) quilt the wall hanging, 47" X 57", by "writing" in gold metalic thread the Christmas story from the Bible (Luke Chapter 2).
In these "detail" shots you can see the "writing".



Wednesday, December 5, 2007

Lymphedema

Updated 3/2017-- photos and all links removed as many are no longer active and it was easier than checking each one.


Lymphedema is a very debilitating and progressive condition with no known cure. The unfortunate patient faces a lifelong struggle.
Frequency:
  • In the United States, the highest incidence of lymphedema is observed following breast cancer surgery, particularly among those who undergo radiation therapy following axillary lymphadenectomy. Among this population, 10-40% develop some degree of ipsilateral upper extremity lymphedema.
  • Worldwide, 140-250 million cases of lymphedema are estimated to exist, with filariasis being the most common cause.
Lymphedema may be classified as primary or secondary, based on underlying etiology.
Primary lymphedema represents a developmental abnormality of the lymphatic system. It is further subdivided into three forms depending on age at presentation. These conditions are most often sporadic, with no family history, and involve the lower extremity almost exclusively.
  • Congenital lymphedema represents all forms that are clinically evident at birth. It accounts for 10-25% of all primary lymphedema cases. Females are affected twice as often as males. The lower extremity is involved 3 times more frequently than the upper extremity. Two thirds of patients have bilateral lymphedema, and this form may improve spontaneously with increasing age. There is a subset of patients with congenital lymphedema who have a familial sex-linked pattern of inheritance, which is termed Milroy disease. It accounts for 2% of primary lymphedema cases. The histology of the lymphatic channels often demonstrates an anaplastic pattern without subcutaneous lymphatic trunks but with normal dermal plexus.
  • Lymphedema praecox is the most common form of primary lymphedema. It is also known as Meige disease. By definition, it becomes clinically evident after birth and before age 35 years. This condition accounts for 65-80% of all primary lymphedema cases and most often arises during puberty. Females are affected 4 times as often as males. About 70% of cases are unilateral, with the left lower extremity being involved more often than the right. Histologically, these patients are likely to demonstrate a hypoplastic pattern, with the lymphatics reduced in caliber and number.
  • Lymphedema tarda does not become clinically evident until age 35 years or older. It is the rarest form of primary lymphedema and accounts for only 10% of cases. Histologically, patients are likely to demonstrate a hyperplastic pattern, with tortuous lymphatics increased in caliber and number. They often display absent or incompetent valves.
All three forms of primary lymphedema likely originate from a developmental abnormality that is present, but not always clinically evident, at birth. Some cases may become evident later in life when a triggering event or worsening of the condition causes the lymphatic transport capacity to exceed the volume of interstitial fluid formation, causing the patient to be unable to maintain normal lymphatic flow.
Secondary lymphedema represents an acquired dysfunction of otherwise normal lymphatics. Secondary lymphedema has an identifiable cause that destroys or renders inadequate the otherwise normal lymphatics.
    • In the United States, it commonly results from damage or removal of regional lymph nodes through surgery (ie axillary dissection), radiation, infection, or tumor invasion or compression.
    • Worldwide, the most common cause is filariasis, the direct infestation of lymph nodes by the parasite Wuchereria bancrofti.
    • Other causes include vein stripping, peripheral vascular surgery, lipectomy, burns, burn scar excision, and insect bites.
    • Recently, there has been an increasing number of morbidly obese patients presenting with lymphedema. "The rise in obesity is also contributing to the numbers of lymphedema patients. Ten years ago Dr. Fife didn't have any patients who weighed 500 pounds. Now, 2% or more of her patients are at this weight or heavier. Why morbid obesity leads to lymphedema is unknown, but one theory is that fat may block the system. "So as everyone gets fatter, we have more lymphedema," Dr. Fife said." --Dec 3, 2007 AMA Newsletter

If you are interested in the pathophysiology, please, read the eMedicine Article by Dr. Don R Revis, Jr, MD. You may also find more information at the links listed in the references below.

Clinical:
Patients present with varying degrees of severity, from mild swelling to severe disabling enlargement with potentially life-threatening complications. Lymphedema develops in a number of stages, from mild to severe:
Stage 1 (spontaneously reversible):
  • Tissue is still at the "pitting" stage, which means that when pressed by fingertips, the area indents and holds the indentation. Usually, upon waking in the morning, the limb(s) or affected area is normal or almost normal size.
Stage 2 (spontaneously irreversible):
  • The tissue now has a spongy consistency and is "non-pitting," meaning that when pressed by fingertips, the tissue bounces back without any indentation forming). Fibrosis found in Stage 2 lymphedema marks the beginning of the hardening of the limbs and increasing size.
Stage 3 (lymphostatic elephantiasis):
  • At this stage the swelling is irreversible and usually the limb(s) is/are very large. The tissue is hard (fibrotic) and unresponsive; some patients consider undergoing reconstructive surgery called "debulking" at this stage.
When lymphedema remains untreated, protein-rich fluid continues to accumulate, leading to an increase of swelling and a hardening or fibrosis of the tissue. The swollen limb(s) in this state becomes a perfect culture medium for bacteria and subsequent recurrent lymphangitis (infections). Furthermore, the untreated lymphedema can lead to a decrease or loss of functioning of the limb(s), skin breakdown, chronic infections and, sometimes, irreversible complications. In the most severe cases, untreated lymphedema can develop into a rare form of lymphatic cancer called Lymphangiosarcoma (most often in secondary lymphedema).
Treatments for Lymphedema
Planning the treatment program depends on the cause of the lymphedema. For example: If the initial signs and symptoms of swelling are caused by infection (redness, rash, heat, blister or pain may indicate an infection), antibiotics will first need to be prescribed. Treating an infection often reduces some of the swelling and discoloration.
If the lymphedema is not caused by infection: Depending on the severity of the lymphedema, the recommended treatment plan should be determined using an approach based on the Complex Decongestive Therapy (CDT) methods which consist of:
  • Manual lymphatic drainage-- Intermittent pneumatic pump compression therapy may also be instituted on an outpatient basis or in the home. These manual lymphatic devices are most appropriate prior to fibrosclerotic evolution, and they assist in preventing fibrosclerotic evolution of the condition. These devices provide sequential active compression from distal to proximal, effectively milking the lymph from the extremity.
  • Bandaging
  • Proper skin care & diet-- Meticulous hygiene is necessary to remove keratinaceous debris and bacteria. Cleanse the skin regularly and dry thoroughly. Regular inspection is necessary to identify any open wounds or developing cellulitis. Bland skin moisturizers applied conservatively may ameliorate cracking and furrowing.
  • Compression garments (sleeves, stockings, devices such as Reid Sleeve, CircAid, Tribute, as well as other alternative approaches)-- should be worn continuously during the day. They may be removed at night when the extremity is elevated in bed, but they should be replaced promptly each morning. To encourage compliance, the elastic compression garments must fit appropriately. This requires that the garment be custom fit when the extremity is decompressed. The garment should also have graduated compression, increasing from distal to proximal, on the affected extremity.
  • Remedial exercises
  • Self-manual lymphatic drainage & bandaging, if instruction is available.
  • Surgical treatment is palliative, not curative, and it does not obviate the need for continued medical therapy. It is reserved for those who do not improve with conservative measures or in cases where the extremity is so large that it impairs daily activities and prevents successful conservative management. The goals of surgical therapy are volume reduction to improve function, facilitation of conservative therapy, and prevention of complications.
If you are a patient with lymphedema:
Continue to follow prophylactic methods at all times to prevent further problems.
  • Avoid exposure to extreme cold, which can be associated with rebound swelling, or chapping of skin.
  • Avoid prolonged ( > 15 minutes) exposure to heat, particularly hot tubs and saunas.
  • Avoid immersing limb in water temperatures above 102° F.
  • Avoid constrictive clothing or jewelry that might have a tourniquet effect.
  • If possible, avoid having blood pressure taken on the at-risk arm.
  • Avoid prolonged standing or sitting or crossing your legs.
  • Wear proper, well-fitting footwear.
  • Skin Care - Avoid trauma/injury and reduce infection risk
  1. Keep extremity clean and dry.
  2. Apply moisturizer daily to prevent chapping/chaffing of skin.
  3. Attention to nail care; do not cut cuticles.
  4. Protect exposed skin with sunscreen and insect repellent.
  5. Use care with razors to avoid nicks and skin irritation.
  6. If possible, avoid punctures such as injections and blood draws.
  7. Wear gloves while doing activities that may cause skin injury (i.e., gardening, working with tools, using chemicals such as detergent).
  8. If scratches/punctures to skin occur, wash with soap and water, apply antibiotics, and observe for signs of infection (i.e. redness).
  9. If a rash, itching, redness, pain, increased skin temperature, fever or flu-like symptoms occur, contact your physician immediately.

FREE Lymphedema Alertband for the arm or leg are available here!

References
Lymphedema by Don R Revis, Jr, MD -- eMedicine Article
Lymphedema -- Vascular Web Home
Morbid Obesity And Lymphedema Management by Caroline E. Fife, MD, Susan Benavides, CLT-LANA, & Gordon Otto, PhD; LymphLink, Vol 19, No 3, July-Sept 2007
Lymphedema -- Mayo Clinic website
18 Steps to Prevention Revised: Lymphedema Risk-Reduction Practices By Saskia R.J. Thiadens, RN--National Lymphedema Network

Tuesday, December 4, 2007

Mesotherapy / Lipodissolve

Updated 3/2017-- photos and all links removed as many are no longer active and it was easier than checking each one.



Sandy over at Junkfood Science recently wrote a post on liplysis, Quest for "thinner-ness" . It is a very well written article and links to another well written article on the same subject by Marnell Jameson in the LA Times, "Weighing in on lipolysis". Both are worth the time spent reading them, especially if you or someone you know are considering the procedure.

"Basically, mesotherapy involves a series of injections that can contain a multiplicity of ingredients, from vasodilators to nonsteroidal anti-inflammatory agents, depending on the medications, enzymes, or hormones that are injected into the fat layer of the skin. ........ It is being used more often now for body contouring and to treat cellulite to reduce body fat. A common injectable is lecithin, which is phosphatidylcholine isoproterenol, a lipolytic agent that actually stimulates beta-adrenergic receptors. Lecithin is common in human bile and is needed for the digestion of dietary fat. The true mechanism of mesotherapy remains unknown, even though it has been widely used in Europe for years to treat cellulite, amid unsubstantiated claims. To my knowledge, no clinical scientific studies have been published in the literature to substantiate mesotherapy. It is conjectured that it starts to increase blood flow as well as lymphatic flow in the mesoderm. This causes shrinkage of fat cells, which dissolve themselves and are then excreted. The problem is the lack of randomized, double-blind studies through institutional review board–approved mechanisms to ensure patient safety. The U.S. Food and Drug Administration has not approved the subcutaneous use of the medications commonly used in mesotherapy. The available reports indicate that the medications may potentially cause immediate or delayed allergic reactions, including urticaria pigmentosa problems at the injection sites. It is inconceivable that plastic surgeons in the United States would embrace any treatment that has not had prior institutional review board approval where patient trials have been performed in approved clinical settings. Clinical trials must be performed in medical institutions to evaluate and validate that mesotherapy does or does not work. Perhaps scientific evidence will bear out that the amount of cellulite and fat removal is valid, but these facts must be substantiated before we can use the medications or perform therapy based on the theory of mesotherapy injections. It is mindboggling to think that a physician would inject patients— or that patients would allow physicians to inject them—with unknown, unproved substances based on hearsay and unsubstantiated clinical findings."--Rod Rohrich, MD (the first article listed below)

There remains a lack of clinical scientific studies.

Remember the adage--"If it seems to good to be true, it probably is." That's what I think of this "lunch-time lipo". Hiring a personal trainer makes more sense and is much better in the long run.
References
Mesotherapy: What Is It? Does It Work?; Plastic & Reconstructive Surgery. 115(5):1425, April 15, 2005; Rohrich, Rod J. M.D.
Mesotherapy for Body Contouring; Plastic & Reconstructive Surgery. 115(5):1420-1424, April 15, 2005; Matarasso, Alan M.D.; Pfeifer, Tracy M. M.D.; Plastic Surgery Educational Foundation DATA Committee
The Science of Mesotherapy: Chemical Anarchy; Spencer A. Brown; Aesthetic Surgery Journal, January 2006 (Vol. 26, Issue 1, Pages 95-98)
Lipodissolve for Subcutaneous Fat Reduction and Skin Retraction;
Diane Irvine Duncan, Franz Hasengschwandtner; Aesthetic Surgery Journal, September 2005, Vol. 25, Issue 5, Pages 530-543
Clinical Safety Data and Standards of Practice for Injection Lipolysis: A Retrospective Study; Diane Irvine Duncan, Roman Chubaty; Aesthetic Surgery Journal, September 2006, Vol. 26, Issue 5, Pages 575-585

Monday, December 3, 2007

ATV Safety and Children

Updated 3/2017-- photos and all links removed as many are no longer active and it was easier than checking each one.
 

There was an article in the Arkansas Democrat-Gazette today regarding All Terrain Vehicle (ATV) Safety and Children. It highlights Dr. Chetan C Shah's paper that he will be presenting later this week. Dr. Shah is a radiology fellow at the University of Arkansas for Medical Sciences (UAMS) and Children's Hospital. He has compiled a decade's worth of cases of injuries from ATV's involving children. He will present on Wednesday (December 5, 2007) at the Radiological Society of North America's annual meeting in Chicago. There are 500 cases include in his study which includes children admitted to ACH with ATV related injuries going back to 1998. More than two-thirds were boys. The average age was 11.5 yr.
The youngest rider was a 6-month-old who was riding with his mother and suffered a fractured thigh bone. The youngest driver was a 2-year-old on a mini ATV who had four toes amputated. There were six deaths, not including children who died at the scenes of accidents.
  • Fractured limbs were found in 208 children--most commonly involving the legs.
  • Head injuries --85 skull fractures, 66 cases of bleeding in the brain, and 59 brain injuries.
  • Lung injuries were found in 36 children.
  • Abdominal injuries were found in 70 children. These included injuries to the spleen, liver, kidneys, or pancreas.
  • There were 12 amputations--including 9 partial foot amputation, one upper-limb amputation, and one below-the knee leg amputation.
  • There were 2 eye socket injuries that were so bad the eyes had to be removed.
Dr. Shah hopes parents will hear about the findings and stop allowing children under 16 to ride ATVs. I support this stand.

In response, an ATV-makers association said in a statement that ATVs are safe for children if the safety guidelines are followed. They include:
  • WEAR SAFETY GEAR - Wear a helmet, eye protection and other protective clothing suitable to the environment at all times. Without proper safety equipment you are putting yourself at unnecessary risk. Further, many of the trails require the proper use of safety equipment in order to ride. A helmet, eye protection, gloves, over-the-ankle boots, long sleeve shirts and long pants are all important parts of your safety gear when riding.
  • NO ALCOHOL OR DRUGS - Do not use alcohol or other drugs when you ride. Operating an ATV while drinking or using drugs is not only unsafe, it is illegal.
  • OBEY THE LAW - Learn the ATV laws in your state and those in the areas you will be riding. Knowledge of the laws will not only help keep you safe but it may help you aviod an expensive ticket or worse.
  • OBEY THE RULES - Obey posted signs and stay on the trails. The quickest way for you to be banned from most riding areas is to fail to follow the trail rules and signs. Further, venturing from marked trails can result in a rider coming face to face with unexpected obstacles such as ditches, drop offs, cliffs, trees, etc. Not smart and not safe!
  • WATCH YOUR SPEED - Always ride at a safe and responsible speed. Know your abilities and don't exceed those levels. Riding at excessive speeds not only endangers you but others around you.
  • NO PASSENGERS - Do not carry passengers on your ATV. Most ATV's are designed for a single rider only. Carrying passengers on an ATV designed for a single rider can upset the balance of the machine and make it more likely to tip or roll over. Some of the newer ATV's are specifically designed for two riders. The wheelbase on these machines is longer. There is a reason for that, safety!
  • GET TRAINED - Do not let young or inexperienced riders operate ATVs without training and supervision. An ATV is a fun machine to ride. However, they are powerful machines and can get away from inexperienced riders just like a motorcycle or automobile can. You wouldn't let someone drive a car without first having some training. Treat an ATV with the same respect. This is especially true for children.
  • MAINTAIN A SAFE DISTANCE - Always maintain a safe distance between riders. Tailgating can lead to collisions and injuries just as it does with automobiles on the road. Give the rider in front of you some space. You never know when they will have to stop quickly or turn sharply to aviod an obstacle. This gives you time to react to the obstacle as well.
  • NEVER RIDE ALONE - Ride with others and let someone know where you are riding. Never ride alone. The same rules applies to many things you do and it should be no different when you are operating your ATV. You never know when you will need help.
  • CHECK THE WEATHER - Be informed of local weather conditions. Many of us forget that the weather has a dramatic affect on the trails we ride. Rain makes trails muddy and slick, snow hides obstacles and ice, sun causes burns and dehydration, etc. Dress and equip yourself appropriately for the weather.
  • KNOW THE AREA YOU RIDE IN - Be aware of a riding areas potential hazards. Are there hidden obstacles on the trails? How deep is that water? How steep is that hill? The better you know the terrain and trails in the area you will be riding the safer you will be. If you don't know the area, find someone who does and ride with them the first few trips. Not only will you be safer but you will learn the trails quicker.
  • CHECK YOUR EQUIPMENT - Make sure your equipment is in top working order. Do the brakes work? Are my tires properly inflated? Is there any damage to the unit? Check you equipment before you go. The worst time to find out something doesn't work is when you need it.
  • CARRY A MAP - Carry a map of the trail or area you intend to travel. It is no fun to get lost. Getting lost can result in your trying to navigate areas above your skill level in an attempt to get back. If you can't get a map get a GPS. Most modern GPS's have a "track back" feature that will allow you to retrace your ride and get back to where you started.
  • RIDE THE RIGHT ATV - Most manufacturers recommend certain size ATV's for certain ages. Most manufacturers recommend an ATV less than 70cc for children under 12, a 70cc to 90cc ATV for children 12 to 16 and an ATV larger than 90cc for people over 16. An ATV that is too large for the rider can be dangerous. Smaller children do not have the strength to control the larger ATV's in difficult situations.
  • USE COMMON SENSE - If all else fails, ask yourself, should i do this? If the answer is NO or I AM NOT SURE then DON'T do it. You have nothing to prove to anyone. Stay safe to ride another day.

  • Other sources for information on topic
    ATV Safety--National AG Safety Database
    ATV Safety Crisis--Consumer Federation
    ATV Safety Tips -- Midwest Trail Riders Assoc
    All terrain vehicles guidelines aimed at saving lives -- Land Transportation NZ








    SurgeXperience 110--call for submissions

    Updated 3/2017-- all links (except to my own posts) removed as many no longer active.

    The 10th edition of SurgeXperiences will be hosted by Dr. Alice over at “Cut on the dotted line”. So feel free to submit a post (or two) regarding your experience with surgery here. The deadline for submission is December 7th.
    And if you missed any of the earlier editions:
    SurgeXperience 101:Pilot --Monash Med Student
    SurgeXperience 102: Barbers --Monash Med Student
    SurgeXperience 103-- Unbounded Medicine
    SurgeXperience 104 -- other things amanzi
    SurgeXperience 105 -- Suture for a Living
    SurgeXperience 106 -- IntraopOrate
    SurgeXperience 107 --Vitum Medicinus
    SurgeXperience 108 -- Aggravated Doc Surg
    SurgeXperience 109 -- Monash Med Student









    Sunday, December 2, 2007

    Methylene Blue and Skin Necrosis

    Updated 3/2017-- photos and all links removed as many are no longer active and it was easier than checking each one.
     

    Sentinel lymph node (SLN) dissection has increased in use for the management of high-risk melanoma and other cancers, such as breast cancer. The procedure identifies an SLN by intradermal or intraparenchymal injection of a blue dye (either isosulfan blue or methylene blue), a radiocolloid, or both around the primary malignancy.
    When isosulfan blue is used there is a 2% incidence of allergic reactions. These include "blue hives" and anaphylaxis. Because of these reactions, the use of methylene blue is becoming more wide spread as no toxicity has been attributed to it.
    The use of methylene blue requires an intraparenchymal injection of 5 mL of 1% methylene blue dye. While methylene blue has had no systemic toxicity attributed to it, it has been associated with a local inflammatory reaction which may lead to skin necrosis at the site of injection. Stradling et al. reported skin lesions in 5 of 24 patients who received intradermal injection of methylene blue dye for lymphatic mapping in breast cancer. The skin lesions included a variety of local inflammatory presentations, including erythematous macular lesions, superficial ulcers, necrotic ulcerations, and abscess formation. After injections were restricted to the deep parenchyma, no further skin lesions were noted. This local toxicity of methylene blue with superficial injection concerns surgeons who perform subareolar injection because of its potential effect on the nipple/areolar complex.

    Prevention
    Methylene Blue should not be given by subcutaneous, so try to inject into the deep dermis or subcutaneous layer. This should help prevent the skin complications.
    "Some individuals have found that dilution of methylene blue (2 mL of methylene blue and 3 mL of saline) allows successful mapping while avoiding this local toxicity (Pat Whitworth, MD, personal communication, May 2004" -- from second reference article.

    Treatment
    Treatment consists of basic wound care.
    1) Keep the wound clean.
    2) Keep the wound moist.
    3) Keep the wound well nourished, which implies reducing or eliminating edema and keeping pressure off the wound.
    4) Debride only as necessary, be conservative.

    References
    Methylene Blue Solution for Injection Data Sheet--MedSafe
    Is Blue Dye Indicated for Sentinel Lymph Node Biopsy in Breast Cancer Patients With a Positive Lymphoscintigram?; Amy C. Degnim, MD, Kevin Oh, MD, Vincent M. Cimmino, MD, Kathleen M. Diehl, MD, Alfred E. Chang, MD, Lisa A. Newman, MD, MPH and Michael S. Sabel, MD; Annals of Surgical Oncology 12:712-717 (2005)
    Adverse skin lesions after methylene blue injections for sentinel lymph node localization; Stradling B, Aranha G, Gabram S; Am J Surg 2002;184:350–2.
    Allergic reactions to isosulfan blue during sentinel node biopsy – a common event; Cimmino VM, Brown AC, Szocik JF, Pass HA; Surgery. 2001;130:439–42. doi:10.1067/msy.2001.116407.
    Dye Rashes; Raimer SS, Quevedo EM, Johnston RV; Cutis. 1999;63:103–106
    The Role of Subareolar Blue Dye in Identifying the Sentinel Node in Patients with Invasive Breast Cancer by K. Mokbel and A. Mostafa-- MedScape Article

    Saturday, December 1, 2007

    Jingle Bell Fun Run

    Updated 3/2017-- all links removed as many are no longer active and it was easier than checking each one.


    The Jingle Bell Fun Run sponsored by the Arthritis Foundation is held the first Saturday of December here in Little Rock, Arkansas. It is a 5K. This is the 16th year. It is a family event as you can see by the following pictures.

    Craig O'Neil and a Mime doing the annoucing.

    The trophies are Jingle Bells.

    Some participants get into the season.

    Kids run, walk, are pulled in wagons, etc
    The one on the left, Hannah Who
    won the custome contest.
    A friendly Great Dane

    This parrot stayed on his owners shoulder
    through the entire race as he walked/jogged.

    There was a dog custome contest.

    A sugar plum princess ran the race,
    and was in the runner custome contest.

    Another custome entry. Fun!

    My race number and shirt.
    I wore these bells as I walked/jogged the 5K.